Singapore, Singapore

Carolyn Gauntlett

This inventor holds 1 USPTO granted patent. Top assignee: Leland Stanford Junior University. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Carolyn Gauntlett. Retrieved from https://idiyas.com/inventor/carolyn-gauntlett

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Carolyn Gauntlett: Innovator in Prostratin Analog Research

Introduction

Carolyn Gauntlett is a notable inventor based in Singapore, recognized for her contributions to the field of medicinal chemistry. She has made significant strides in the development of prostratin analogs and related compounds, which hold promise for therapeutic applications.

Latest Patents

Gauntlett holds a patent for "Prostratin analogs, bryostatin analogs, prodrugs, synthetic methods, and methods of use." This patent encompasses various embodiments that provide for prostratin analogs, bryostatin analogs, and prodrugs, along with methods for their synthesis and application. Her work in this area is crucial for advancing the understanding and utilization of these compounds in medical science.

Career Highlights

Currently, Carolyn Gauntlett is affiliated with Leland Stanford Junior University, where she continues her research and innovation in the field. Her academic and professional journey reflects a commitment to exploring new frontiers in medicinal chemistry.

Collaborations

Some of her notable coworkers include Paul A Wender and Lars V Heumann, who have collaborated with her on various research projects, contributing to the advancement of their shared goals in the field.

Conclusion

Carolyn Gauntlett's work in developing prostratin analogs and related compounds showcases her innovative spirit and dedication to scientific advancement. Her contributions are paving the way for future research and potential therapeutic applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…